van Diepen Sean, Alemayehu Wendimagegn G, Zheng Yinggan, Theroux Pierre, Newby L Kristin, Mahaffey Kenneth W, Granger Christopher B, Armstrong Paul W
Divisions of Critical Care and Cardiology, University of Alberta, Edmonton, AB, Canada.
Canadian VIGOUR Centre, University of Alberta, Edmonton, AB, Canada.
J Thromb Thrombolysis. 2016 Oct;42(3):376-85. doi: 10.1007/s11239-016-1390-z.
Coronary plaque rupture mediating acute ST segment elevation myocardial infarction (STEMI) is associated with a systemic inflammatory response. Whether early temporal changes in inflammatory biomarkers are associated with angiographic and electrocardiographic markers of reperfusion and subsequent clinical outcomes is unclear. In the APEX-AMI biomarker substudy, 376 patients with STEMI had inflammatory biomarkers measured at the time of hospital presentation and 24 h later. The primary outcome was the 90-day composite of death, shock, or heart failure. Secondary reperfusion outcomes were (1) worst least residual ST segment elevation (ST-E: <1 mm, 1 to <2 mm, ≥2 mm) and (2) post-percutaneous coronary intervention (PCI) TIMI flow grade (0/1/2 vs 3) and TIMI myocardial perfusion grade (TMPG 0/1 vs 2/3). The 90-day incidence of death, shock or heart failure was 21.3 % in this cohort. Electrocardiographic reperfusion (worst residual ST-E <1 mm, 1 to <2 mm, ≥2 mm) was associated with differences in 24 h change in N-terminal proB-type natriuretic peptide (NT-proBNP) (1192.8, 1332.5, 1859.0 ng/mL; p = 0.043) and the pro-inflammatory cytokines Interleukin (IL)-6 (14.0, 13.6, 22.1 pg/mL; p = 0.016), IL-12 (-0.5, -0.9, -0.1 pg/mL; p = 0.013), and tumor necrosis factor α (TNFα) (1.0, 0.6, 3.6 pg/mL; p = 0.023). Angiographic reperfusion (TMPG 0/1 vs 2/3) was associated with changes in median NT-proBNP (2649.3, 1382.7 ng/mL; p = 0.002) and IL-6 (28.7, 15.1; p = 0.040). After adjustment for baseline covariates, the 24 h change in the pro-inflammatory cytokine TNFα [hazard ratio (HR) 0.49; 95 % CI 0.26-0.95; p = 0.035] and the anti-inflammatory cytokine IL 10 (HR 1.41; 95 % CI 1.06-1.87; p = 0.018) were independently associated with the primary composite outcome. Successful coronary reperfusion was associated with less systemic inflammatory response and greater temporal inflammatory changes were independently associated with higher 90-day composite of death, shock, or heart failure. These findings provide support for an association between success of reperfusion, an acute STEMI inflammatory response and subsequent clinical outcomes.
介导急性ST段抬高型心肌梗死(STEMI)的冠状动脉斑块破裂与全身炎症反应相关。炎症生物标志物的早期时间变化是否与再灌注的血管造影和心电图标志物以及随后的临床结局相关尚不清楚。在APEX-AMI生物标志物子研究中,376例STEMI患者在入院时和24小时后测量了炎症生物标志物。主要结局是90天内死亡、休克或心力衰竭的复合结局。次要再灌注结局为:(1)最严重的残余ST段抬高(ST-E:<1mm、1至<2mm、≥2mm);(2)经皮冠状动脉介入治疗(PCI)后的TIMI血流分级(0/1/2 vs 3)和TIMI心肌灌注分级(TMPG 0/1 vs 2/3)。该队列中90天内死亡、休克或心力衰竭的发生率为21.3%。心电图再灌注(最严重残余ST-E<1mm、1至<2mm、≥2mm)与N末端B型脑钠肽原(NT-proBNP)24小时变化差异(1192.8、1332.5、1859.0ng/mL;p=0.043)以及促炎细胞因子白细胞介素(IL)-6(14.0、13.6、22.1pg/mL;p=0.016)、IL-12(-0.5、-0.9、-0.1pg/mL;p=0.013)和肿瘤坏死因子α(TNFα)(1.0、0.6、3.6pg/mL;p=0.023)相关。血管造影再灌注(TMPG 0/1 vs 2/3)与NT-proBNP中位数变化(2649.3、1382.7ng/mL;p=0.002)和IL-6(28.7、15.1;p=0.040)相关。在对基线协变量进行调整后,促炎细胞因子TNFα的24小时变化[风险比(HR)0.49;95%CI 0.26-0.95;p=0.035]和抗炎细胞因子IL-10(HR 1.41;95%CI 1.06-1.87;p=0.018)与主要复合结局独立相关。成功的冠状动脉再灌注与较低的全身炎症反应相关,而更大的时间炎症变化与更高的90天死亡、休克或心力衰竭复合结局独立相关。这些发现为再灌注成功、急性STEMI炎症反应和随后的临床结局之间的关联提供了支持。